IRCT20210201050197N4已完成未知
Study of bioequivalence of 5 mg Apixaban tablets in healthy volunteers after single dose oral administration
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years（—）
- 性别
- All
入选标准
- •Healthy volunteer
- •Age: 18-50 year
排除标准
- •History of liver, kidney and cardiovascular diseases that can affect drug clearance from body
- •History of taking any medication in the last two weeks
- •Creatinine above 2
研究者
相似试验
招募中
Unknown
Investigating the in vivo bioequivalence of Apixaban tabletIn the present study, the products will be administered to healthy volunteers..IRCT20220211053992N10Tabriz University of Medical Sciences24
已完成
不适用
Comparative in vivo evaluation of 2 ?Apixaban 5 mg Tablet formulations.IRCT20180620040164N37Actover Pharmaceutical Co.24
尚未招募
不适用
Comparative bioequivalence study of the Apixaban 5-mg Tablets manufactured by Darman Yab Darou Company-.IRCT20130313012810N10Darman Yab Darou Pharmaceutical Company24
尚未招募
1 期
Bioequivalence of AbacavirHIV InfectionsPatients seropositive to Human Immunodeficiency Virus (HIV).Human Immunodeficiency VirusVirus DiseasesImmune System DiseasesImmunologic Deficiency SyndromesSexually Transmitted Diseases, ViralRNA Viruses InfectionsRetroviridae InfectionsLentiviruses InfectionsSexually Transmitted DiseasesRPCEC00000252Center for Pharmaceutical Research and Development, Havana, Cuba30
已完成
1 期
Bioequivalence Study of Generic Apixaban Tablet 5 mgHealthy subjectsBioequivalenceApixabanTCTR20230621009Duopharma Biotech Berhad26